Tech sharing, not tech hoarding
Covid-19, global solidarity, and the failed responsibility of the pharmaceutical industry
Bibliographic Data
| ID | 20501034 |
|---|---|
| Authors | Geiger (0000-0002-2400-7333, University College Dublin), Susi Geiger, Nicole Gros (0000-0001-6047-7714, National College of Ireland, corresponding author) |
| Year | 2024 |
| Volume | 31 |
| Issue | 3 |
| Pages | 567-582 |
| Publication date | 2024-04-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Organization (JOURNAL) |
| Journal identifiers | ISSN: 1350-5084 • E-ISSN: 1461-7323 |
| Publisher | SAGE Publications (PUBLISHER • US) |
| DOI | 10.1177/13505084221145666 |
| OpenAlex | W4319785834 |
| Language | EN |
| Citations received | 5 |
| References cited | 36 |
The Covid-19 pandemic has highlighted the importance of health technologies to mitigate against the spread of the disease and improve care, dominantly including life-saving vaccines. But the pandemic has also highlighted that the current biopharmaceutical business model, based on the enclosure of these technologies and on the immense accumulation of capital it enables, leads to vast inequalities in healthcare particularly in low and middle-income countries. We believe that the pharmaceutical industry has a moral duty to enable and enact global solidarity through tech sharing instead of tech hoarding, but judging by current technology transfer practices we question their willingness to assume their role in organizing healthcare markets through solidaristic principles. In the absence of a voluntary adoption of solidaristic principles and practices by biopharmaceutical firms, the institutionalization of global solidarity as a fundamental organizing principle for healthcare markets is necessary to strengthen resilience and know-how globally. With this call, we add to existing conceptualizations of solidarity by (a) introducing a global level of solidarity and (b) thinking through the concept not as an abstract humanistic stance but as a concrete organizing principle for global healthcare markets
Business · Economic growth · Economics · Health care · Law and economics · Political science · Public relations · Solidarity · Biomedical Ethics and Regulation · Innovation and Socioeconomic Development · Law · Pharmaceutical Economics and Policy
Solidarity in Biomedicine and Beyond
Pharmocracy
South African Aids Activism and Global Health Politics
Global impact of the first year of Covid-19 vaccination
Discourse and Deinstitutionalization
Global Solidarity is Necessary to End the Covid-19 Pandemic
Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for Covid-19
Overcoming enduring inequalities in Global Value Chains? Interpreting the case of Brazil’s Covid-19 vaccine supply through a chess metaphor
Post-capitalistic politics in the making
Two Conceptions of Solidarity in Health Care
Global health inequalities and the need for solidarity
Building the weak hand of the state
Covid-19 and the case for global development
A Model of Innovation, Technology Transfer, and the World Distribution of Income
Market Failures and Market Framings
The Tragedy of the Anticommons
(De-)assetizing pharmaceutical patents
| Unique citing works | 5 |
|---|---|
| Citations per year | 1,67 |
| Citation span | 2023 - 2026 (4) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 5 |